A study comparing the chemical oxidation of drug candidates with cell-based metabolism (liver microsomes, hepatocytes) shows that biomimetic oxidation can replace the biological approach, thus allowing access to large quantities of metabolites, which can also be used for the preparation of new products.
一项比较药物候选化合物的
化学氧化与基于细胞的代谢(肝微粒体、肝细胞)的研究表明,仿生氧化可以替代
生物学方法,从而获得大量代谢物,这些代谢物也可以用于新产品的制备。